S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
NASDAQ:STAA

STAAR Surgical (STAA) Stock Price, News & Analysis

$33.31
+2.07 (+6.63%)
(As of 03/1/2024 ET)
Today's Range
$31.60
$33.81
50-Day Range
$27.67
$34.00
52-Week Range
$26.66
$73.13
Volume
717,585 shs
Average Volume
643,242 shs
Market Capitalization
$1.63 billion
P/E Ratio
77.47
Dividend Yield
N/A
Price Target
$44.38

STAAR Surgical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
33.2% Upside
$44.38 Price Target
Short Interest
Bearish
13.20% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.73
Upright™ Environmental Score
News Sentiment
0.01mentions of STAAR Surgical in the last 14 days
Based on 31 Articles This Week
Insider Trading
Acquiring Shares
$4.76 M Bought Last Quarter
Proj. Earnings Growth
326.67%
From $0.15 to $0.64 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.69 out of 5 stars

Medical Sector

80th out of 951 stocks

Ophthalmic Goods Industry

1st out of 7 stocks


STAA stock logo

About STAAR Surgical Stock (NASDAQ:STAA)

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAA Stock Price History

STAA Stock News Headlines

STAAR Surgical (NASDAQ:STAA) Trading 7.9% Higher
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Staar Surgical Co.
STAAR Surgical Company Q4 Income Rises
STAAR Surgical Q4 2023 Earnings Preview
A Preview Of Staar Surgical's Earnings
STAA Dec 2024 60.000 put
STAA Sep 2024 32.500 put
STAA Mar 2024 15.000 put
See More Headlines
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2024
Today
3/02/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
882
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$44.38
High Stock Price Target
$57.00
Low Stock Price Target
$33.00
Potential Upside/Downside
+33.2%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
10 Analysts

Profitability

Net Income
$38.76 million
Pretax Margin
10.45%

Debt

Sales & Book Value

Annual Sales
$322.42 million
Cash Flow
$0.78 per share
Book Value
$7.90 per share

Miscellaneous

Free Float
48,328,000
Market Cap
$1.63 billion
Optionable
Optionable
Beta
0.83

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report














STAA Stock Analysis - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" STAA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View STAA analyst ratings
or view top-rated stocks.

What is STAAR Surgical's stock price target for 2024?

10 brokerages have issued 12-month price targets for STAAR Surgical's stock. Their STAA share price targets range from $33.00 to $57.00. On average, they anticipate the company's stock price to reach $44.38 in the next year. This suggests a possible upside of 33.2% from the stock's current price.
View analysts price targets for STAA
or view top-rated stocks among Wall Street analysts.

How have STAA shares performed in 2024?

STAAR Surgical's stock was trading at $31.21 at the start of the year. Since then, STAA stock has increased by 6.7% and is now trading at $33.31.
View the best growth stocks for 2024 here
.

When is STAAR Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our STAA earnings forecast
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Monday, February, 26th. The medical instruments supplier reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.17 by $0.01. The medical instruments supplier had revenue of $76.27 million for the quarter, compared to analyst estimates of $75.94 million. STAAR Surgical had a net margin of 6.62% and a trailing twelve-month return on equity of 8.73%. STAAR Surgical's quarterly revenue was up 19.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.04 EPS.

What ETFs hold STAAR Surgical's stock?
What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $335.0 million-$340.0 million, compared to the consensus revenue estimate of $349.0 million.

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Broadwood Capital Inc. (21.59%), Vanguard Group Inc. (11.20%), Baillie Gifford & Co. (9.11%), Jackson Square Partners LLC (3.47%), Palo Alto Investors LP (2.82%) and Geneva Capital Management LLC (1.88%). Insiders that own company stock include Aimee S Weisner, Broadwood Partners, LP, Caren L Mason, Elizabeth Yeu Lin, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends
.

How do I buy shares of STAAR Surgical?

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does STAAR Surgical have any subsidiaries?
The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
This page (NASDAQ:STAA) was last updated on 3/3/2024 by MarketBeat.com Staff